Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China
In this letter, gastroenterologists in China describe how they managed patients with inflammatory bowel disease, including cessation of treatment with infliximab or other immunosuppressive treatments, and practical guidance such limiting outings, and wearing face masks when out.
Source:
Lancet Gastroenterology and Hepatology